Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Children Cancer, Solid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01844661
What this trial is testing

Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors.

Who this might be right for
ChildrenSolid TumorsMetastases
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 20
Early research (Phase 1)Study completedNCT00019630
What this trial is testing

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Soft Tissue SarcomaChildhood Liver CancerBone Cancer+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00107458
What this trial is testing

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 26
Testing effectiveness (Phase 2)Study completedNCT00004078
What this trial is testing

Irinotecan in Treating Children With Refractory Solid Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+18 more
Children's Oncology Group 181
Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT07043894
What this trial is testing

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Who this might be right for
Solid TumorsHematological TumorChildren+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Not applicableLooking for participantsNCT05151718
What this trial is testing

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

Who this might be right for
Ependymoma of BrainPediatric Solid Tumor
Institut Claudius Regaud 370
Early research (Phase 1)Study completedNCT00005844
What this trial is testing

Oxaliplatin in Treating Children With Advanced Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
St. Jude Children's Research Hospital 26
Not applicableStudy completedNCT01645436
What this trial is testing

Physical Activity in Pediatric Cancer (PAPEC)

Who this might be right for
Pediatric Cancer
Universidad Europea de Madrid 49
Testing effectiveness (Phase 2)Ended earlyNCT04671901
What this trial is testing

Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, ChildhoodSolid Carcinoma
Memorial Sloan Kettering Cancer Center 2
Early research (Phase 1)Study completedNCT00321581
What this trial is testing

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

Who this might be right for
Refractory or Recurrent Solid TumorsAcute Myelogenous Leukemia
National Cancer Institute (NCI) 18
Not applicableStudy completedNCT00674193
What this trial is testing

Evaluating Dactinomycin and Vincristine in Young Patients With Cancer

Who this might be right for
Childhood Acute Lymphoblastic LeukemiaChildhood RhabdomyosarcomaChildhood Soft Tissue Sarcoma+5 more
Children's Oncology Group 158
Early research (Phase 1)WithdrawnNCT00458744
What this trial is testing

Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Children's Oncology Group
Large-scale testing (Phase 3)Looking for participantsNCT05770037
What this trial is testing

DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers

Who this might be right for
Haematological MalignancyMalignant NeoplasmLymphoproliferative Disorders+8 more
Cancer Research UK 30
Testing effectiveness (Phase 2)Study completedNCT00003898
What this trial is testing

Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation

Who this might be right for
Oral ComplicationsUnspecified Childhood Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 120
Testing effectiveness (Phase 2)Study completedNCT00187109
What this trial is testing

Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy

Who this might be right for
Germ Cell TumorsHepatic CancerNeuroblastoma+2 more
St. Jude Children's Research Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02637687
What this trial is testing

Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 154
Testing effectiveness (Phase 2)UnknownNCT01558453
What this trial is testing

Oxaliplatin for Children With Solid Tumors

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Sidnei Epelman 20
Testing effectiveness (Phase 2)Study completedNCT00389584
What this trial is testing

Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Adults+4 more
University of California, Davis 30
Next Page